login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NEURAXIS INC (NRXS) Stock News
USA
-
NYSE Arca
- NYSEARCA:NRXS -
US64134X2018
-
Common Stock
2.78
USD
0 (0%)
Last: 12/4/2025, 12:09:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NRXS Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: NeurAxis, Inc.
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
17 days ago - By: Zacks Investment Research
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
23 days ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
24 days ago - By: Benzinga
Neuraxis Earnings Preview
a month ago - By: NeurAxis, Inc.
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
a month ago - By: Benzinga
- Mentions:
IVA
PMI
GNTA
ADIL
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
4 months ago - By: Zacks Investment Research
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
7 months ago - By: NeurAxis, Inc.
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
a month ago - By: NeurAxis, Inc.
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
4 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
4 months ago - By: NeurAxis, Inc.
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
6 months ago - By: NeurAxis, Inc.
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
6 months ago - By: NeurAxis, Inc.
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
7 months ago - By: NeurAxis, Inc.
NeurAxis Announces $5.0 Million Registered Direct Offering
7 months ago - By: Yahoo Finance
- Mentions:
MS
COMP
UNH
CWGL
...
Equities Rise Intraday as Markets Weigh Macro Data, Fed Chair's Comments
7 months ago - By: Zacks Investment Research
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
7 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
7 months ago - By: NeurAxis, Inc.
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
7 months ago - By: Zacks Investment Research
- Mentions:
JNJ
CSCO
AMZN
EFX
...
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems
8 months ago - By: NeurAxis, Inc.
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
9 months ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
9 months ago - By: NeurAxis, Inc.
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
11 months ago - By: NeurAxis, Inc.
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
11 months ago - By: NeurAxis, Inc.
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
a year ago - By: NeurAxis, Inc.
NeurAxis Inc. Issues Letter to Shareholders
a year ago - By: NeurAxis, Inc.
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
a year ago - By: NeurAxis, Inc.
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
a year ago - By: NeurAxis, Inc.
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
a year ago - By: NeurAxis, Inc.
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
a year ago - By: NeurAxis, Inc.
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
Please enable JavaScript to continue using this application.